We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$224B
AUM Growth
+$21B
Cap. Flow
+$7.48B
Cap. Flow %
3.33%
Top 10 Hldgs %
24.57%
Holding
10,190
New
1,427
Increased
4,227
Reduced
3,278
Closed
1,044

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$798M
2
T icon
AT&T
T
+$527M
3
MCHP icon
Microchip Technology
MCHP
+$472M
4
NFLX icon
Netflix
NFLX
+$446M
5
PNC icon
PNC Financial Services
PNC
+$444M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$694M
2
KEY icon
KeyCorp
KEY
+$401M
3
DE icon
Deere & Co
DE
+$322M
4
CSX icon
CSX Corp
CSX
+$318M
5
NXPI icon
NXP Semiconductors
NXPI
+$314M

Sector Composition

Rank Sector Weight
1 Financials 5.93%
2 Technology 4.66%
3 Healthcare 4.45%
4 Industrials 4.14%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCTX icon
8576
CALL
Lineage Cell Therapeutics
LCTX
$268M
$64K ﹤0.01%
+31,204
New +$65.5K
LEE icon
8577
Lee Enterprises
LEE
$183M
$64K ﹤0.01%
+2,433
New +$71.5K
ZIXI
8578
PUT
DELISTED
Zix Corporation
ZIXI
$64K ﹤0.01%
+11,600
New +$64.3K
NEOS
8579
CALL
DELISTED
Neos Therapeutics, Inc
NEOS
$64K ﹤0.01%
+13,200
New +$74.9K
SGYP
8580
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$64K ﹤0.01%
+37,640
New +$67.4K
AST
8581
PUT
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$64K ﹤0.01%
48,900
+15,900
+48% +$24.7K
FGP
8582
PUT
DELISTED
Ferrellgas Partners, L.P.
FGP
$63K ﹤0.01%
28,400
-16,900
-37% -$53K
FELP
8583
PUT
DELISTED
Foresight Energy LP
FELP
$63K ﹤0.01%
+15,800
New +$60.5K
ACET
8584
PUT
DELISTED
Aceto Corp
ACET
$63K ﹤0.01%
27,900
+1,200
+4% +$3.83K
CGEN icon
8585
Compugen
CGEN
$227M
$62K ﹤0.01%
+16,133
New +$56.4K
IDEX
8586
PUT
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$62K ﹤0.01%
+130
New +$51.8K
ZOM
8587
DELISTED
Zomedica Corp.
ZOM
$62K ﹤0.01%
+33,410
New +$71.5K
EMITF
8588
DELISTED
Elbit Imaging Ltd
EMITF
$62K ﹤0.01%
29,675
-2,354
-7% -$5.34K
CEI
8589
DELISTED
Camber Energy, Inc
CEI
0
RIBT
8590
DELISTED
RiceBran Technologies
RIBT
$62K ﹤0.01%
2,156
+1,075
+99% +$30K
BINI
8591
DELISTED
Bollinger Innovations
BINI
0
REKR icon
8592
Rekor Systems
REKR
$98.6M
$61K ﹤0.01%
50,305
+38,093
+312% +$56.1K
VIVE
8593
CALL
DELISTED
VIVEVE MED INC
VIVE
$61K ﹤0.01%
+23
New +$65.2K
LGCY
8594
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$61K ﹤0.01%
12,615
-9,448
-43% -$49.4K
FRO icon
8595
PUT
Frontline
FRO
$9.21B
$60K ﹤0.01%
10,300
-200
-2% -$1.06K
HBM icon
8596
PUT
Hudbay
HBM
$11.9B
$60K ﹤0.01%
11,800
+300
+3% +$1.49K
INSG icon
8597
CALL
Inseego
INSG
$77.2M
$60K ﹤0.01%
+1,550
New +$43K
OCSL icon
8598
PUT
Oaktree Specialty Lending
OCSL
$1.15B
$60K ﹤0.01%
+4,033
New +$59.5K
TAC icon
8599
TransAlta
TAC
$4.06B
$60K ﹤0.01%
10,648
-30,748
-74% -$172K
SRNE
8600
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$60K ﹤0.01%
13,607
-64,075
-82% -$355K

Similar funds

Ken Griffin's Q3 2018 Portfolio in Review

As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.

By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.

  • Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
  • Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
  • Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
  • Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
  • Ken Griffin opened 1,427 new positions and closed 1,044 in Q3 2018.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.

Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.